logo

OTC shift will 'centralise risk on CCPs'


Regulatory changes have centralised risk on central counterparties (CCPs) instead of eliminating systemic risk, according to the findings of new market research.

The GreySpark Partner’s report looks at the current over-the-counter (OTC) derivatives landscape and the possible impact on it from upcoming regulation in its current form.

Operations, risk, credit, control and compliance departments are identified as likely to feel the greatest impact in the wake of changes to functionality, additional systems integration and overall architectural adjustments which will be necessary to reach the standards set by...

The rest of this article is for subscribers only. Would you like to take a free trial?

Free trial

  • News & Analysis access
  • Extensive data searches
  • Access to archive
  • Weekly newsletter